Advanced Micro Devices, Inc. (AMD)
Wall Street sets AMD stock price target for the next 12 months
The stock of Advanced Micro Devices (NASDAQ: AMD) has been on something of a roller coaster ride in recent months, having recorded both stellar rallies and staggering drops.
AMD: My Highest Conviction Play -- Betting Big Again
The AI market is expected to surge to $780-$990 billion by 2027, with workloads growing 25-35% annually. The AI accelerator market is projected to grow at an impressive 70% CAGR through 2027, driven by rising hardware demand. With 192GB HBM3 memory and 5.3TB/s bandwidth, Advanced Micro Devices, Inc.'s MI300X targets memory-intensive AI inference tasks with unmatched efficiency.
What's Happening With AMD Stock?
AMD stock (NASDAQ:AMD) has seen a meaningful sell-off over the past week, declining by about 11% over the last five trading days. The stock also remains down by about 25% since early 2024.
Is AMD Stock Due for a Bounce Back Year in 2025?
Advanced Micro Devices (AMD 3.33%), also known as AMD, has been a surprisingly underperforming tech stock over the past year. In 2024, it declined by 18% even despite its promising growth opportunities as a top artificial intelligence (AI) chip maker.
Investing $10,000 in These 3 Growth Stocks 10 Years Ago Would Have Created a Portfolio Worth $3.4 Million Today
It's tempting to try and pick stocks that you think might double or triple in value in a year or two. However, the best gains often come over the long term, and sometimes they can come in unexpected ways.
3 Blockbuster Semiconductor Stocks to Buy for a Happy New Year in 2025
According to Morgan Stanley, a group of four tech giants (Microsoft, Amazon, Alphabet, and Meta Platforms) could spend a combined $300 billion building data center infrastructure for artificial intelligence (AI) development during 2025.
Regenxbio: Wet AMD ABBV-RGX-314 Results Remain On Track For 2026
Regenxbio's rolling BLA submission completion of RGX-121 for the treatment of patients with MPS II expected in Q1 of 2025. Partnership established with Nippon Shinyaku to develop RGX-121 and RGX-111 for the treatment of patients with MPS II and MPS I respectively. Data from both the ASCENT and ATMOSPHERE pivotal studies, using ABBV-RGX-314 for the treatment of patients with Wet Age-Related Macular Degeneration, expected in 2026.
AMD Q4 Preview: Be Greedy When Others Are Fearful (Rating Upgrade)
AMD's Data Center segment, driven by AI demand, is forecasted to achieve robust revenue growth, contributing to a projected 35% stock CAGR over the next three years. With a 35% margin of safety, an FY2027 price target of $280, and a discounted intrinsic value of $175, AMD's current $115 price represents a strong buying opportunity. Geopolitical tensions (e.g., Taiwan) and recession risks pose challenges, but AMD's AI positioning and my cash strategy offer resilience and support a bullish outlook.
Regenxbio Inc.: Why It Is Down, And When It Will Go Up Again
Regenxbio Inc. remains undervalued despite its cutting-edge AAV gene therapy technology and promising assets like RGX-314 for wet AMD and RGX-121 for MPS II. RGX-314, partnered with AbbVie, targets wet AMD with global regulatory submissions expected in H1 2026; RGX-121 has a rolling BLA submission expected to complete in Q1 2025. Financially, RGNX has a market cap of $344mn and a cash balance of $279mn, bolstered by a recent $110mn upfront fee from Nippon Shinyaku.
What AMD, Nvidia, Onto, and TSMC Stock Investors Should Know About Recent AI Semiconductor Updates
In today's video, I discuss Nvidia (NVDA -1.10%) and other semiconductor companies. To learn more, check out the short video, consider subscribing, and click the spe cial offer link below.
AMD Shares Hint At A Reversal As Charts Show Bullish Stick Sandwich Following A Double Downgrade From HSBC
Shares of chipmaker Advanced Micro Devices Inc. AMD are most likely poised for a reversal as its candlesticks show a rare pattern despite a double downgrade from HSBC on Jan. 8.
AMD's New Bull, KBH Leads Homebuilder Rally, MA Downgrade & V Upgrade
KB Home (KBH) got a much needed rally after posting an earnings beat and better-than-expected outlook. In the credit card space, Seaport Research downgrades Mastercard (MA) but upgrades Visa (V).
